NCT07827885Completed
20-Fr Versus 24-Fr Chest Drains After Uniportal VATS Lobectomy for NSCLC
Prospective Randomized Comparative Evaluation of Different Chest Drainage Devices in Patients Undergoing Lung Lobectomy
Source: ClinicalTrials.gov · Last updated 18 Sept 2026
Brief summary (registry, in English)
This randomized clinical trial compared two different chest drain sizes, 20 Fr and 24 Fr, in patients undergoing lung lobectomy for lung cancer. The study aimed to determine whether the size of the chest drain affects postoperative recovery. Outcomes included the presence of pneumothorax and pleural effusion, postoperative pain, subcutaneous emphysema, prolonged air leak, duration of chest drainage, and length of hospital stay. A total of 80 patients were randomly assigned in a 1:1 ratio to receive either a 20-Fr or a 24-Fr chest drain.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 80 (actual)
- First submitted
- 4 Sept 2026
- Start date
- 24 Jul 2025
- Primary completion date
- 31 Jan 2026
- Lead sponsor
- Fondazione Policlinico Universitario Campus Bio-Medico
- Diseases
- Lung cancer, Childhood cancers
- NCT number
- NCT07827885
What you commit to
- Study type: Interventional
- Participants enrolled: 80
- From 24 Jul 2025 to the primary completion date, 31 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous ipsilateral pulmonary resection.
Other
- Neoadjuvant chemoradiotherapy.
- FEV1/FVC \<70%.
- Clinical stage beyond IIB according to the eighth or ninth edition of the TNM classification.
- Macrobullous emphysema on computed tomography.
- pregnant and breastfeeding women
Who the study is looking for
- Patients undergoing pulmonary lobectomy with systematic mediastinal lymphadenectomy for lung cancer using a uniportal video-assisted thoracoscopic approach.
- FEV1/FVC \>70%.
- Clinical stage up to and including stage IIB according to the eighth or ninth edition of the TNM classification.
- No morphological evidence of macrobullous emphysema on computed tomography.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fondazione Policlinico Universitario Campus Bio-Medico Coordinator of this site? Confirm its status | Rome | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.